MCAM and neoplasm: We identified 12 markers for LUAD3 (Supplementary Fig. 4), including DCBLD2, MCAM and VIM, which are considered EMT markers that are usually associated with tumor dedifferentiation and poor prognosis in NSCLC44–46.